A Double-blind, Randomized, Placebo-controlled, 5-way Crossover, Multicenter, Single-dose, Dose-ranging Study to Compare the Efficacy and Safety of Albuterol Spiromax and ProAir HFA in Adult and Adolescent Subjects Ages 12 and Older With Persistent Asthma
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2015
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 26 Feb 2013 Results presented at the 69th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 03 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 Actual patient number (72) added as reported by ClinicalTrials.gov.